These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 36297228)

  • 41. Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis.
    Ho MH; Lamont RJ; Chazin WJ; Chen H; Young DF; Kumar P; Xie H
    Mol Oral Microbiol; 2018 Dec; 33(6):430-439. PubMed ID: 30298683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iron and heme utilization in Porphyromonas gingivalis.
    Olczak T; Simpson W; Liu X; Genco CA
    FEMS Microbiol Rev; 2005 Jan; 29(1):119-44. PubMed ID: 15652979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotyping of Porphyromonas gingivalis in Relationship to Virulence.
    Amano A; Choi YH; Takeuchi H
    Methods Mol Biol; 2021; 2210():53-59. PubMed ID: 32815127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral Porphyromonas gingivalis Infections Increase the Risk of Alzheimer's Disease: A Review.
    Fu Y; Xu X; Zhang Y; Yue P; Fan Y; Liu M; Chen J; Liu A; Zhang X; Bao F
    Oral Health Prev Dent; 2023 Jan; 21():7-16. PubMed ID: 36651311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Porphyromonas gingivalis Tyrosine Phosphatase Php1 Promotes Community Development and Pathogenicity.
    Jung YJ; Miller DP; Perpich JD; Fitzsimonds ZR; Shen D; Ohshima J; Lamont RJ
    mBio; 2019 Sep; 10(5):. PubMed ID: 31551334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Porphyromonas gingivalis outer membrane vesicles on gingipain-mediated detachment of cultured oral epithelial cells and immune responses.
    Nakao R; Takashiba S; Kosono S; Yoshida M; Watanabe H; Ohnishi M; Senpuku H
    Microbes Infect; 2014 Jan; 16(1):6-16. PubMed ID: 24140554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dental follicle cells-derived small extracellular vesicles inhibit pathogenicity of Porphyromonas gingivalis.
    Huang Y; Liu L; Liu Q; Huo F; Hu X; Guo S; Tian W
    Oral Dis; 2023 Jul; 29(5):2297-2309. PubMed ID: 35509129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral infection with a periodontal pathogen alters oral and gut microbiomes.
    Simas AM; Kramer CD; Weinberg EO; Genco CA
    Anaerobe; 2021 Oct; 71():102399. PubMed ID: 34090994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Uniquely Altered Oral Microbiome Composition Was Observed in Pregnant Rats With
    Walkenhorst MS; Reyes L; Perez G; Progulske-Fox A; Brown MB; Phillips PL
    Front Cell Infect Microbiol; 2020; 10():92. PubMed ID: 32211345
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of curcumin on growth, biofilm formation and virulence factor gene expression of Porphyromonas gingivalis.
    Kumbar VM; Peram MR; Kugaji MS; Shah T; Patil SP; Muddapur UM; Bhat KG
    Odontology; 2021 Jan; 109(1):18-28. PubMed ID: 32279229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
    Han X; LaRosa KB; Kawai T; Taubman MA
    Vaccine; 2014 Jan; 32(2):297-303. PubMed ID: 24051159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of in vivo-induced antigen technology (IVIAT) to identify virulence factors of Porphyromonas gingivalis.
    Wallet SM; Chung J; Handfield M
    Methods Mol Biol; 2010; 666():181-95. PubMed ID: 20717786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P. gingivalis in Periodontal Disease and Atherosclerosis - Scenes of Action for Antimicrobial Peptides and Complement.
    Hussain M; Stover CM; Dupont A
    Front Immunol; 2015; 6():45. PubMed ID: 25713575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Porphyromonas gingivalis gingipains in multi-species biofilm formation.
    Bao K; Belibasakis GN; Thurnheer T; Aduse-Opoku J; Curtis MA; Bostanci N
    BMC Microbiol; 2014 Oct; 14():258. PubMed ID: 25270662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effects of azithromycin on the adherence ability of Porphyromonas gingivalis.
    Kan P; Sasaki H; Inaba K; Watanabe K; Hamada N; Minabe M
    J Periodontol; 2019 Aug; 90(8):903-910. PubMed ID: 30690740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Research progress in the pathogenic mechanisms of
    Du LY; Sun XL; Yu WX; Ren JY; Gu XM; Zhou YM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Oct; 53(10):703-707. PubMed ID: 30392229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunological Pathways Triggered by
    de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
    Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
    [No Abstract]   [Full Text] [Related]  

  • 58. Bismuth drugs tackle Porphyromonas gingivalis and attune cytokine response in human cells.
    Cheng T; Lai YT; Wang C; Wang Y; Jiang N; Li H; Sun H; Jin L
    Metallomics; 2019 Jul; 11(7):1207-1218. PubMed ID: 31179464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of
    Rafiei M; Kiani F; Sayehmiri F; Sayehmiri K; Sheikhi A; Zamanian Azodi M
    Med J Islam Repub Iran; 2017; 31():62. PubMed ID: 29445691
    [No Abstract]   [Full Text] [Related]  

  • 60. Label-free quantitative proteomic analysis of the oral bacteria Fusobacterium nucleatum and Porphyromonas gingivalis to identify protein features relevant in biofilm formation.
    Ali Mohammed MM; Pettersen VK; Nerland AH; Wiker HG; Bakken V
    Anaerobe; 2021 Dec; 72():102449. PubMed ID: 34543761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.